After the meal, the four sisters and brothers went back to SUSTech directly.

Ou Yiran and Yun Lei returned to the investment department to continue their unfinished trading career.

For stock market investors, especially big funds like Ou Yiran and Yun Lei, this period can be described as an inch of time and an inch of gold, and it is not possible to be sloppy.

After the close of trading at three o'clock, the husband and wife opened the medical device sector in the listed company and began to carefully select the merger and acquisition targets.

If you don't look at the good performance, these companies have high stock prices, have their own fist products and markets, and have a good life, but usually the asking price will be ridiculously high, which is not suitable for mergers and acquisitions.

Companies with huge losses in performance don't look at it, such companies are riddled with lawsuits, and there are many financial traps that make you unable to guard against them.

Only among the companies with small losses and small profits, choose which company is in the gap between survival, they have a difficult operation, the product technology content is low, the market competition is weak, the asking price is usually not very high, and it is easy to negotiate terms.

And then there's the region. The more economically developed the area, the higher the asking price will be because of the cost of land and the price of land.

According to statistics, among the 108 medical device companies, the science and technology innovation board alone accounts for 40%. After the elimination of these companies.

Then exclude the companies above the profit triangle of annual report performance, and exclude the companies with annual report performance losses of more than five corners, there are actually not many companies to choose from.

In addition, most of the medical device companies are concentrated in the economically developed areas of the Yangtze River Delta and the Pearl River Delta.

After some careful comparison and combing, it was screened out:

Kelitai, located in the Yangtze River Delta, has a share capital of 710 million yuan, full circulation, and its performance has fluctuated around 0.1 yuan for many years. It is mainly engaged in the R&D, production and sales of minimally invasive interventional systems. Strong scientific research ability. The current stock price is 7.8 yuan.

Baoyute, located in the Pearl River Delta, has a small share capital, 170 million full circulation, and its performance has fluctuated around 0.2 yuan for many years. It is mainly engaged in the R&D and sales of medical device products. Strong scientific research ability, the current stock price is 13.6 yuan.

Rongda Medical, located in the Special Economic Zone, has a total share capital of 850 million shares, 600 million shares in circulation, and its performance has fluctuated around 0.1 yuan in the past three years. It is mainly engaged in the overall solution of modern hospitals, the production and sales of medical devices, and the construction of hospitals. The scientific research ability is average, and the current stock price is 4.3 yuan. Involved in a lawsuit with an amount of 300 million yuan.

Limande, located in Beijing-Tianjin-Hebei, has a total share capital of 550 million shares, 420 million shares in circulation, and a performance of 0.1 yuan in the past three years. It is mainly engaged in the production and sales of biochemical reagents and diagnostic instruments. The scientific research ability is average, and the current stock price is 6.5 yuan. Recently, it has been involved in litigation of 60 million yuan.

Boffin Medical, located in Beijing-Tianjin-Hebei, has a total share capital of 820 million shares and 800 million shares in circulation. It is mainly engaged in the research and development, production and sales of medical testing products. The current stock price is 6.8 yuan.

Weichuang Medical, located in the Yangtze River Delta, has a total share capital of 290 million shares, 190 million shares in circulation, and a performance of 0.2 in the past three years. It is mainly engaged in R&D, production and sales of childcare equipment, with strong scientific research capabilities, and the current stock price is 10.3 yuan.

After further comparison between Ou Yiran and Yunlei, he focused his attention on the company Rongda Medical, which is located in the Special Economic Zone.

The advantage of this company is that the share capital is moderate, the company is located in the region, and there is a tendency to be close to the water. The disadvantage is that there is a lawsuit of 300 million yuan.

The second company is also located in the Pearl River Delta, Baoyute, this company has strong scientific research capabilities, but the share capital is too small, and the extension space is not enough.

The third company, located in the Yangtze River Delta, has the advantage of moderate equity and strong scientific research ability, and the disadvantage is cross-regional operation.

However, considering that the Demon Capital Research Institute is also in the area, it invisibly offsets that disadvantage.

"At the end of the week, we will take the principle of near first and then far, and first find out these three companies." Ou Yiran suggested.

Yun Lei said with a smile: "Overall, I like Baoyute very much, this company has strong scientific research capabilities, and although the share capital is a little smaller, we can increase the issuance after we move in." Hehe, with the appeal of the third-generation intelligent and enterprising artificial intelligence heart, those who participate in the additional issuance must be eager to do it! ”

"Among the several companies screened, Baoyute has the best performance and the smallest share capital. If there is a slight flurry, the stock price will continue to rise and fall, which is very difficult to operate. If you choose this company, you must be prepared to acquire at a premium. ”

Yun Lei knew this and asked, "Which one do you prefer?" ”

"In terms of mergers and acquisitions, the other two are actually better suited than Paulette. Those two companies have been struggling for several years, just like babies waiting to be fed and in desperate need of breast milk. Coupled with the moderate circulation and low stock price, it is very suitable for us to lurk in quietly. ”

"Okay, then let's get in touch with them first and get to the bottom of it. Whoever has urgent restructuring requirements, and who is more likely to cooperate with our merger and reorganization, will merge whomever he wants. ”

"Tomorrow is Friday, and the morning after tomorrow, we will go to Rongda Medical for a field visit."

"In what name shall we go?"

"Let's just take the form of an investor survey, so it won't attract attention."

"Why don't you call the company's securities affairs representative?" Yun Lei asked.

Ou Yiran said: "We have been doing stocks for so long, and this is the first time we have conducted field research in a listed company. Why don't you give a phone call and see how the company's securities representative will respond? ”

Yun Lei smiled: "Okay, I'll try the management quality of the leader of this listed company, if the first impression of the representative of the thing is good, she may be the hero of that company." ”

"What if the first impression is bad?"

"They deserve to miss our god of wealth." Yun Lei spoke, looked at the phone number of the listed company, and dialed it.

"Toot." As soon as it rang, the other party picked it up.

"Hey, who are you?" A female voice with a spoken Fujian and Cantonese voice asked.

"I am an ordinary investor in your company, and I plan to go to your company on Saturday morning for field research, can you receive it?"

"Okay, no problem. Can you leave your contact details and name? ”

"My surname is Yun, and my mobile phone number is XXX." Yun Lei told the other party.

"May I ask Ms. Yun, what time will you arrive at our company in the morning?" The securities representative asked.

"About half-past nine!"

"Okay, when you are almost there, give me a call in advance, and I will pick you up at the gate."

"Okay!"

"Bye-bye, Ms. Yun."

"Bye-bye."

After hanging up the phone, Yun Lei said with a smile: "It seems that the management level of this company is good, at least the securities affairs representative can be conscientious." ”

"Maybe the securities affairs representative is in a happy mood today, and he is right in front of the phone!"

Yun Lei came up with an idea: "Why not, you will try another one later?" ”

Ou Yiran smiled: "This is a good idea, is it a coincidence, or is it as always, just give it a try?" ”

The husband and wife chatted for a while, about half an hour, Ou Yiran took out his mobile phone and dialed the call.

"Hey, are you here to investigate?" As soon as the phone rang, the other party asked bluntly.

Ou Yiran asked knowingly: "How do you know?" ”

"Mr. Bu said that the people who made this call were either here to investigate, or investors who consulted the problem."

Ou Yiran deliberately said: "How do you know that I am not an investor in consulting questions?" ”

"Sir, I am the customary casual question."

"Okay, I plan to go to your company on Saturday afternoon for on-site research, can you receive it?"

"No problem, may I ask your surname, sir, can you leave your contact information?"

"My surname is Ou, and my phone ......"

"Mr. Ou, can you tell me what time it will be on Saturday afternoon?"

"Half past three!"

"What's good, Mr. Ou, when you are about to arrive, give me a call, and I will pick you up at the factory gate."

"Okay."

"Mr. Naou, bye-bye."

"Bye-bye."

"Not a word of standard diplomatic language has changed." After putting down the phone, Ou Yiran smiled.

Yun Lei said: "If the company's managers are so conscientious, why has the company been in a state of low profits for many years? ”

Ou Yiran said: "This is not necessarily, many times, you have to look at the market competitiveness of the product, just look at the professionalism and service of the leader, can not solve all the problems." ”

Yun Lei asked, "Why do you say that it's half past three in the afternoon, isn't it fooling people?" ”

Ou Yiran said with a smile: "Only by saying this can we test whether the securities affairs representative is dedicated." ”

"But the day after tomorrow is Saturday, which will make people wait in the company in vain."

"It's okay, after the morning research, just tell her about it!"

Yun Lei nodded and said with a smile: "It's the same!" ”

"Do you want to call Ouzhou and Jiang Yang to go together?" Ou Yiran asked.

"Supposedly they should have been called. But now they're celebrities, and if they're recognized, it's going to be very difficult for us to merge and acquire. ”

"They can wear masks!"

Yun Lei said: "That's not possible, when I enter the office, people serve tea, whether to drink it or not." If you drink it, you may expose the stuffing, and if you don't drink it, people will think they are arrogant. ”

Ou Yiran smiled and said: "Such a big matter, are the two of us going to call the shots for them?" ”

"Is there anything wrong with parents making decisions for their sons?"

"Otherwise, let Fei'er and Jingxin go, a few more people, a few more pairs of eyes and minds, and you can find more problems."

Yun Lei nodded: "That's fine." ”

"Then you call them both now and let them know sooner."

"On Saturdays, they have time, just a little less sleep." Although Yun Lei said that, she still picked up her mobile phone and dialed it, telling them her thoughts.

Time flies so fast, it's Saturday in a flash, and after eating breakfast early in the morning, they set off and go to the gate of Rongda Medical Company to meet.

When the car was about to arrive, Yun Lei called the securities affairs representative. When they arrived, Ke Feier and Shui Jingxin were already waiting there.

In front of the porter, I saw a woman of about thirty years old standing there.

Seeing Ou Yiran's car arrive, the woman immediately stepped forward to say hello, and then asked the doorman to open the door.

Ou Yiran's car drove in first, and Kefeier's car followed, parking the car in the parking lot of the office building.

The securities representative came over and invited them to the conference room.

Ou Yiran first looked at the factory area, the windows are bright and tiled, and the wide boulevard is separated by several production areas of different sizes and styles.

The office building is only three floors and covers an area of more than 1,000 square meters, but it is unique and original, looking like a giant capsule, surrounded by willows among flowers.

The securities affairs representative probably saw what he meant, smiled and said, "If the gentleman wants, we can take a look at the periphery." ”

Yun Lei asked, "Can you go inside the factory and see?" ”

"I'm sorry Ms. Yun, the medical device production plant is sterile and dust-free, not sterilized, and you are not allowed to enter without professional protective clothing."

Ke Fei'er gently tugged Yun Lei and said, "Mother Yun, she is right. ”

"Okay, let's take a look at the periphery."

The representative of the securities affairs took a group of four of them to observe the production process that could be visited.

Ke Feier can see that this company has a high degree of automation, and although the specifications are not as rigorous as the second-generation soul artificial intelligence heart production workshop of Wandao Jiahe Medical Company, it still reflects a very high level of technology.

The securities affairs representative walked and spoke, and after about half an hour, he returned to the original point.

"Ms. Yun, we can go to the conference room to talk about other issues." Secretary Dong said with a smile.